The aim of this study was to investigate the heart rate variability (HRV) after resistance training with and without vascular occlusion. It was hypothesized that low intensity (LI) with vascular occlusion (LIO) would elicit comparable postexercise HRV responses with that of high intensity (HI) without vascular occlusion. Nine subjects undertook 4 experimental sessions of leg press exercise on different days: (a) 1 repetition maximum (1RM) test, (b) 4 sets of 8 repetitions + 1 set until exhaustion at 80% of 1RM without vascular occlusion (HI), (c) 4 sets of 16 repetitions + 1 set until exhaustion at 40% of 1RM with vascular occlusion (LIO), and (d) 4 sets of 16 repetitions + 1 set with the number of repetitions equal to the last set of LIO but at 40% of 1RM without vascular occlusion (LI). Heart rate variability was analyzed 10 minutes, 20 minutes, 30 minutes, 1 hour, 5 hours, and 24 hours after the HI, LIO, and LI sessions. The HI session increased the heart rate (HR) and reduced the root mean square of the successive difference of R-R intervals (RMSSD) and log-transformed high-frequency (lnHF) power during prolonged recovery (HR = 5 hours; RMSSD = 30 minutes; lnHF = 1 hour) at a greater magnitude when compared with LIO and LI. Despite the same intensity of exercise for LIO and LI, the occlusion delayed the recovery of HR and HRV variables. Postexercise blood lactate concentration was moderate to strongly correlated with peak HR (r = 0.87), RMSSD (r = -0.64), and lnHF (r = -0.68). This study has demonstrated that LIO was able to reduce cardiac autonomic stress when compared with HI.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1519/JSC.0000000000000245 | DOI Listing |
The broad spectrum of clinical manifestations caused by peripheral arterial disease [PAD] and the morphologic heterogeneity of associated atherosclerotic lesions present a considerable management challenge. Endovascular interventions are recognized an effective treatment for PAD. Within this revascularization strategy the role of atherectomy debulking modalities continue to evolve.
View Article and Find Full Text PDFProg Cardiovasc Dis
December 2024
Department of Cardiology, Columbia University Irving Medical Center/New York Presbyterian Hospital and the Cardiovascular Research Foundation, 161 Fort Washington Avenue, New York, NY 10032, United States of America.
Ischemic cardiomyopathy (ICM) is characterized by myocardial dysfunction due to myocardial ischemia, associated with the presence of significant coronary artery disease (CAD). We provide a comprehensive review of the current evidence for coronary revascularization in ICM, including consideration of the different modalities of coronary artery bypass grafting and percutaneous coronary intervention . In addition to a contemporary assessment of the literature, we aim to provide real-world insights and perspectives to guide clinical decision-making in this heterogeneous and complex patient population.
View Article and Find Full Text PDFAm Heart J
December 2024
Department of cardiology, Guy's and St Thomas' NHS Foundation Trust, Harefield Hospital, London, UK; King's College London, London, UK.
Background: ST-segment elevation myocardial infarction (STEMI) is treated with immediate primary percutaneous coronary intervention (pPCI) to restore coronary blood flow in the acutely ischaemic territory, but is associated with reperfusion injury limiting the benefit of the therapy. No treatment has proven effective in reducing reperfusion injury. Transcoronary hypothermia has been tested in clinical studies and is well tolerated, but is generally established after crossing the occlusion with a guidewire therefore after initial reperfusion, which might have contributed to the neutral outcomes.
View Article and Find Full Text PDFCardiovasc Ther
January 2025
Department of Pediatric Cardiology Saarland University Medical Center, Homburg 66421, Germany.
The objective of this study is to evaluate the clinical application and primary outcome of transcatheter embolization using Amplatzer™ Vascular Plug (AVP) Type 2 and Type 4 in different congenital cardiovascular malformations. This is a single-center retrospective observational cohort study. We analyzed clinical and imaging data of 36 patients retrospectively who received transcatheter embolizations of the following malformations using AVP: systemic-to-pulmonary collateral arteries (SPCA), patent ductus arteriosus (PDA), ventricular septal defects (VSD), and aberrant pulmonary sequestration arteries (PSA).
View Article and Find Full Text PDFJACC Adv
November 2024
Inova Schar Heart and Vascular, Inova Fairfax Medical Campus, Falls Church, Virginia, USA.
While there has been a proliferation of training and practice paradigms in the realm of noncoronary interventions, coronary disease remains the predominant pathology necessitating interventional cardiology expertise. The landscape of coronary disease has also experienced a significant transformation due to rapidly evolving technologies, clinical application of mechanical circulatory support and other device innovations, and increasing acuity and complexity of patients. The modern interventional cardiologist is subject to challenges including decreasing coronary procedural volume, need to maintain clinical and financial productivity, and often also requirements of continued scholastic pursuit.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!